Modulation of intestinal epithelial permeability by chronic small intestinal helminth infections
- PMID: 38648862
- DOI: 10.1111/imcb.12749
Modulation of intestinal epithelial permeability by chronic small intestinal helminth infections
Abstract
Increased permeability of the intestinal epithelial layer is linked to the pathogenesis and perpetuation of a wide range of intestinal and extra-intestinal diseases. Infecting humans with controlled doses of helminths, such as human hookworm (termed hookworm therapy), is proposed as a treatment for many of the same diseases. Helminths induce immunoregulatory changes in their host which could decrease epithelial permeability, which is highlighted as a potential mechanism through which helminths treat disease. Despite this, the influence of a chronic helminth infection on epithelial permeability remains unclear. This study uses the chronically infecting intestinal helminth Heligmosomoides polygyrus to reveal alterations in the expression of intestinal tight junction proteins and epithelial permeability during the infection course. In the acute infection phase (1 week postinfection), an increase in intestinal epithelial permeability is observed. Consistent with this finding, jejunal claudin-2 is upregulated and tricellulin is downregulated. By contrast, in the chronic infection phase (6 weeks postinfection), colonic claudin-1 is upregulated and epithelial permeability decreases. Importantly, this study also investigates changes in epithelial permeability in a small human cohort experimentally challenged with the human hookworm, Necator americanus. It demonstrates a trend toward small intestinal permeability increasing in the acute infection phase (8 weeks postinfection), and colonic and whole gut permeability decreasing in the chronic infection phase (24 weeks postinfection), suggesting a conserved epithelial response between humans and mice. In summary, our findings demonstrate dynamic changes in epithelial permeability during a chronic helminth infection and provide another plausible mechanism by which chronic helminth infections could be utilized to treat disease.
Keywords: barrier; epithelium; helminths; intestine; permeability; tight junctions.
© 2024 The Authors. Immunology & Cell Biology published by John Wiley & Sons Australia, Ltd on behalf of the Australian and New Zealand Society for Immunology, Inc.
References
REFERENCES
-
- Horowitz A, Chanez‐Paredes SD, Haest X, Turner JR. Paracellular permeability and tight junction regulation in gut health and disease. Nat Rev Gastroenterol Hepatol 2023; 20: 417–432.
-
- Garcia‐Hernandez V, Quiros M, Nusrat A. Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation: intestinal epithelial claudins. Ann NY Acad Sci 2017; 1397: 66–79.
-
- Mules TC, Inns S, Le Gros G. Helminths' therapeutic potential to treat intestinal barrier dysfunction. Allergy 2023; 78: 2892–2905.
-
- Shea‐Donohue T, Sullivan C, Finkelman FD, et al. The role of IL‐4 in Heligmosomoides polygyrus‐induced alterations in murine intestinal epithelial cell function. J Immunol 2001; 167: 2234–2239.
-
- Moyat M, Lebon L, Perdijk O, et al. Microbial regulation of intestinal motility provides resistance against helminth infection. Mucosal Immunol 2022; 15: 1283–1295.
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
